Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huaier Granule for Prevention of Recurrence in Hepatocarcinoma
NCT01770431Phase 4Completed
- Sponsor
- Qidong Gaitianli Medicines Co., Ltd.
- Start
- Aug 2011
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of huaier granule in hepatocellular carcinoma (HCC), sponsored by Qidong Gaitianli Medicines Co., Ltd.. Started Aug 2011; status: completed.
02
Drugs
huaier granule
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01770431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01770431.